【what is the difference between a flounder and a fluke】PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
New York,what is the difference between a flounder and a fluke New York--(Newsfile Corp. - May 1, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi logo
If you invested in PharmaCielo stock or options between June 21, 2019 and March 2, 2020
and would like to discuss your legal rights,
click here
:
www.faruqilaw.com/PCLOF
.
There is no cost or obligation to you.
You can also contact us by calling
Richard Gonnello
toll free at
877-247-4292
or at
212-983-9330
or by sending an e-mail to
.
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26
th
Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased PharmaCielo securities between June 21, 2019 and March 2, 2020 (the "Class Period"). The case,
Daniel Gabbard v. PharmaCielo Ltd. et al
, No. 20-cv-02182 was filed on March 6, 2020, and has been assigned to Judge Philip S. Gutierrez.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) PharmaCielo engaged in an undisclosed related party transaction with General Extract; (2) PharmaCielo engaged in misleading transactions and loans with General Extract and XPhyto; (3) PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed; (4) the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants; (5) PharmaCielo's Cauca Department land has never been utilized by the Company and is idle; and (6) as a result , Defendants' public statements were materially false and/or misleading at all relevant times.
Specifically, on March 2, 2020, Hindenburg Research published a report (the "Report") explaining that PharmaCielo had failed to disclose: (1) transactions with related parties; (2) misleading business transactions and loans with General Extract and XPhyto; (3) the delayed state of its Research Technology and Processing Centre's construction; and (4) the poor state of its Rionegro Growing Facility.
On this news, PharmaCielo's stock fell from a closing price of $1.42 per share over the next two trading days to $0.9068 per share on March 3, 2020- a $0.5132 or 36.14% drop.
Story continues
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding PharmaCielo's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (
www.faruqilaw.com
). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit
https://www.newsfilecorp.com/release/55240
View comments
-
This Broker Just Slashed Their Freelance.com SA (EPA:ALFRE) Earnings ForecastsChina's manufacturing sector shrinks more than expected in January - Caixin PMIWyoming Estate TaxGLOBAL ECONOMY-Factory activity in Asia weakens on China slowdown, trade disputesThe Bar Harbor Bankshares (NYSEMKT:BHB) Share Price Is Down 38% So Some Shareholders Are Getting WorriedBRIEF-Jangho Group's Unit Offers To Buy All Issued Shares In Australia's HealiusSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – LXRX‘Stranger Things’ Renewed for Third Season at NetflixHalozyme Therapeutics, Inc. Just Recorded A 24% EPS Beat: Here's What Analysts Are Forecasting NextSoros buys IGD stake in bet on Italian real estate
下一篇:Baker Hughes Snaps Up Compact Carbon Capture For Energy Transition Path
- ·Hedge Funds Souring On E*TRADE Financial (ETFC)
- ·AZZ (AZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- ·Will eBay (EBAY) Beat Estimates Again in Its Next Earnings Report?
- ·Laverne Cox Recalls 'Trauma' of Watching Loved Ones Die of HIV/AIDS and Wondering, 'Am I Next?'
- ·Earnings Preview: Diodes (DIOD) Q3 Earnings Expected to Decline
- ·7 of Hillary Clinton’s Biggest Flip-Flops
- ·BRIEF-Yunnan Water Investment Co Updates On Award Of Project
- ·You Can Own This Lotus Cortina Raced by Some of the World's Greatest Drivers
- ·Brexit trade talks in 'difficult phase', British minister says
- ·ScHoolboy Q Announces New Album ‘Blue Lips’ Coming Next Month
- ·Hedge Funds Have Never Been This Bullish On TransDigm Group Incorporated (TDG)
- ·India govt steps up farm support, gives tax relief in pre-election budget
- ·American Airlines slashes flights but has no plans to halt U.S. service
- ·The Hague Evidence Convention’s Rarely-Used Private Commissioner Provision May Be a Viable Option for Cross-Border Discovery
- ·GLOBAL MARKETS-Asian shares off 4-month high as China data disappoints
- ·Some Love For a Tattered Industrials ETF
- ·Kratos Defense (KTOS) to Post Q1 Earnings: What's in Store?
- ·BRIEF-iDreamsky Technology Holdings Says Shenzhen iDreamsky Entertainment Entered Investment Agreement
- ·Argentina says collected 319.921 bln pesos in Dec tax revenue
- ·3 Reasons Why I Bought Stocks on Monday
- ·IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against PaySign, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- ·7 of the best laptop brands of 2019
- ·JGB yields track global peers lower, curve flattens
- ·Who Has Been Selling Virtusa Corporation (NASDAQ:VRTU) Shares?
- ·Blockchain Could Make Dismantling Nuclear Warheads More Secure: UK Report
- ·Honda plans to front-load UK production ahead of Brexit
- ·High-Yield ETF Rout Widens Gap With Benchmarks
- ·Pompeo, Brazil foreign minister discuss democracy support for Cuba, Venezuela, Nicaragua
- ·Another number paints a bleak picture of manufacturing in China
- ·UPDATE 1-Toshiba likely to miss quarterly earnings deadline for 3rd time-sources
- ·German Court Issues a Dangerous Verdict for the ECB
- ·Paul Weiss, Partner Promotions and the Path to Diversity in Big Law
- ·What Does MRC Global Inc.’s (NYSE:MRC) Share Price Indicate?
- ·Have Insiders Been Selling Parker-Hannifin Corporation (NYSE:PH) Shares?
- ·Wall Street Week Ahead: Bond investors look for Fed to justify steepening yield curve
- ·Apple’s iPhone Warning Comes Years Too Late